Bladder Cancer Support Team
The Bladder Cancer Support Team was started to serve the needs of patients who are diagnosed with bladder cancer, as well as their families. It is funded by a generous grant from the Department of Urology’s National Institutes of Health-funded Bladder Cancer Specialized Program of Research Excellence (SPORE).
The primary goal of the Bladder Cancer Support Team is patient education. Toward this end, the Support Team organizes patient and caregiver meetings, events, and lecture series. The Support Team educates patients and caregivers regarding risk factors and the relationship between bladder cancer and occupational and lifestyle exposures, helps patients navigate treatment options and centers, works to improve patient access to cutting-edge therapies, including SPORE-initiated research, and solicits patient input into the direction of our translational research. These efforts improve the overall quality of care for patients with bladder cancer and promote patient involvement through education.
The Bladder Cancer Support Team also works to improve public awareness of bladder cancer and its causes. The Support Team is involved with the minority outreach program for underserved populations and high-risk groups—individuals with an occupational exposure related to bladder cancer and individuals with nicotine dependence.
We currently have 600 members, which consist of bladder cancer patient survivors, family members, and other interested individuals.
The researchers and physicians at M. D. Anderson Cancer Center are fully committed to the Bladder Cancer Support Team and its goals.
The members of the Support Team include:
- Thomas Touzel, GU SPORE Patient Advocate
- Jane Dinney, Volunteer Coordinator
- Ashish Kamat, MD, Medical Director
- Ann-Marie Parsad, Administrative Executive
If you’d like to be contacted about the Bladder Cancer Support Team, fill out our secure online form. You will be added to our mailing list and will receive the support team newsletter, published four times a year.
Tom Touzel, GU SPORE Patient Advocate
Jane Dinney, Volunteer Coordinator
Why Choose MD Anderson?
- Innovative bladder cancer treatments including gene therapy, immunotherapy and chemotherapy
- Minimally invasive laparoscopic and robotic procedures to treat bladder cancer
- Advanced reconstruction techniques
- Highly skilled and experienced surgeons
- Nationally recognized research program offers clinical trials of new bladder cancer therapies